Neil Senzer

This inventor holds 11 USPTO granted patents and 8 published patent applications and 2 EPO patents. Top assignee: Gradalis, Inc.. Active years: 2013-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neil Senzer. Retrieved from https://idiyas.com/inventor/neil-senzer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 8)

% Patents Active = 90.9

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 52(Granted Patents)

Location History:

Delray Beach, FL (US) (2017 - 2018)
Dallas, TX (US) (2013 - 2019)

Company Filing History:

11 out of 23

Gradalis, Inc.

patents

Years Active: 2013-2019

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10253331 - Furin-knockdown and GM-CSF-augmented (FANG) cancer vaccine (2019-04-09),

2. 9914977 - Individualized cancer therapy (2018-03-13),

3. 9790518 - Furin-knockdown and GM-CSF-augmented (FANG) cancer vaccine (2017-10-17),

4. 9695422 - Furin-knockdown bi-functional RNA (2017-07-04),

5. 9528991 - Individualized cancer therapy (2016-12-27),

6. 9382589 - Individualized cancer therapy (2016-07-05),

7. 9157084 - Furin-knockdown bi-functional RNA (2015-10-13),

8. 9132146 - Furin-knockdown and GM-CSF-augmented (FANG) cancer vaccine (2015-09-15),

9. 8916530 - Individualized cancer therapy (2014-12-23),

10. 8906874 - Bi-functional shRNA targeting Stathmin 1 and uses thereof (2014-12-09),

11. 8603991 - Individualized cancer therapy (2013-12-10),

Title: The Pioneering Work of Inventor Neil Senzer

Introduction: Neil Senzer is an innovative inventor based in Dallas, TX, who has made significant contributions to cancer treatment through his groundbreaking patents. With a total of 11 patents to his name, Senzer's work demonstrates a commitment to advancing medical science, particularly in the field of oncology.

Latest Patents: Two of Neil Senzer's latest patents include the "Furin-knockdown and GM-CSF-augmented (FANG) cancer vaccine" and "Individualized cancer therapy." The FANG cancer vaccine focuses on genetically modifying autologous cancer vaccines to enhance the immune response against tumors while targeting the immunosuppressive effects of TGF-β. His individualized therapy involves a meticulous process to analyze cancer and normal tissues, enabling the development of targeted RNA interference therapies to modify gene expression in patients.

Career Highlights: Senzer's career is marked by his dedication to cancer research and innovative therapeutic solutions. His work has led to advancements that empower personalized medicine, creating treatment options that cater specifically to individual patients based on their unique cancer profiles.

Collaborations: Throughout his career, Neil Senzer has collaborated with notable experts including John J Nemunaitis and Donald Rao. These collaborations have fostered a dynamic exchange of ideas and expertise, enhancing the impact of his research and accelerating the development of cutting-edge treatments.

Conclusion: Neil Senzer's contributions to cancer therapy exemplify the power of innovation in medicine. His latest patents showcase a forward-thinking approach to treatment, highlighting the importance of personalized medicine in the fight against cancer. As he continues to push the boundaries of medical science, Senzer remains a prominent figure in the realm of cancer research and therapeutic development.

Profile summary based on public USPTO records.